化学
安培法
链霉亲和素
生物素化
胶质纤维酸性蛋白
免疫分析
辣根过氧化物酶
检出限
结合
色谱法
生物化学
分子生物学
电化学
抗体
生物素
电极
病理
免疫组织化学
酶
免疫学
物理化学
数学分析
生物
医学
数学
作者
Göksu Ozcelikay,María Gamella,Mehmet Altay Ünal,Kıvılcım Gücüyener,Ana Montero‐Calle,Rodrigo Barderas,José Manuel Pingarrón,Susana Campuzano,Síbel A. Özkan
出处
期刊:Talanta
[Elsevier BV]
日期:2022-05-05
卷期号:246: 123526-123526
被引量:11
标识
DOI:10.1016/j.talanta.2022.123526
摘要
Glial fibrillary acidic protein (GFAP) is a member of the intermediate filament family of proteins with increased levels in serum and cerebrospinal fluid of patients with Alzheimer disease (AD) and other neurodegenerative diseases (NDs), such as vascular dementia (VD). This work describes the first magnetic microbeads (MBs)-based electrochemical immunoplatform for GFAP determination. The platform design comprises a sandwich immunoassay implemented on the MBs surface and amperometric transduction at single-use screen-printed carbon electrodes (SPCEs). Micro-sized carboxylic acid magnetic particles (COOH-MBs) were modified with a specific capture antibody (CAb) to selectively link the target protein, which was sandwiched with a biotinylated detector antibody (btn-DAb) further conjugated with a streptavidin-peroxidase (Strep-HRP) conjugate. Amperometric transduction was performed at SPCEs upon capturing the magnetic bioconjugates on their surface and through the hydrogen peroxide/hydroquinone (H2O2/HQ) system. The immunoplatform achieved a limit of detection of 67 pg mL-1 for the amperometric detection of standards and selectivity compatible with clinical applicability to assist in minimally invasive NDs diagnosis and prognosis. The MBs-based immunoplatform was applied with good results to determine the endogenous content of GFAP in protein brain extracts without matrix effect and using just 6.25 ng of sample per determination. Furthermore, the developed methodology was capable of differentiating between healthy subjects and patients diagnosed with VD and AD in only 2 h, providing accurate results in line with those obtained by an ELISA kit that used the same immunoreagents.
科研通智能强力驱动
Strongly Powered by AbleSci AI